Hard-tech companies, like BioSens8, face significant hurdles to success, especially in their early stages. These startups typically spend their first few years and a substantial proportion of their early funding just to create the facilities needed to develop their technology.
START.nano offers early-stage, deep-tech startups discounted access to MIT.nano’s state-of-the-art laboratories:
Their goal is to minimize the cost of launching a nascent idea, to help increase the survival rate of promising companies, and to shorten the time it takes for their innovations to reach the market.
Comments